IDT IDT CORP
Price Chart
Executive Summary
IDT Corp filed an 8-K reporting the resignation of director Irwin Katsof (not due to any disagreement) and the appointment of William Conkling to the board. Conkling, a former CEO of Rafael Holdings and current CCO of Protara Therapeutics, will serve as Audit Committee Chair and Audit Committee Financial Expert. This is a routine board refresh with no material financial impact.
Actionable Insight
Routine board refresh with no financial or operational implications. Monitor for any future 8-Ks related to committee changes or strategic shifts, but no immediate trading action warranted.
Key Facts
- Irwin Katsof resigned from the board on June 9, 2026; resignation was not due to any disagreement with the company
- William Conkling, age 55, appointed to the board on June 9, 2026; term expires at the 2026 annual meeting
- Conkling is independent per NYSE standards and will serve as Audit Committee Chair, Audit Committee Financial Expert, and member of Compensation and Corporate Governance Committees
- Conkling is currently Chief Commercial Officer of Protara Therapeutics and previously served as CEO of Rafael Holdings (NYSE: RFL) from Feb 2022 to May 2025
- Conkling is eligible for the standard Non-Employee Director Compensation Program (cash and equity awards)
Financial Impact
No financial figures disclosed; routine director compensation only
Risk Factors
- No material risks identified from this filing
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-020335 |
| Document: 0001437749-26-020335-index-headers.html | 0001437749-26-020335 |
| Document: 0001437749-26-020335-index.html | 0001437749-26-020335 |
| Document: 0001437749-26-020335.txt | 0001437749-26-020335 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $54.95 awaiting T+1 | awaiting T+1 | — | $54.63 (−0.58%) |
|
Jun 11, 2026
1d ago
|
8-K
| $54.95 awaiting T+1 | awaiting T+1 | — | $54.63 (−0.58%) |
|
Jun 10, 2026
2d ago
|
Press Release
| $55.48 awaiting T+1 | awaiting T+1 | — | $54.63 (−1.53%) |
|
Jun 3, 2026
9d ago
|
8-K
| $55.57 $56.08 | ▲ +0.92% | ▲ +3.52% | $54.63 (−1.69%) |
|
Jun 3, 2026
9d ago
|
Press Release
| $54.03 $55.57 | ▲ +2.85% | ▲ +2.45% | $54.63 (+1.11%) |
|
May 29, 2026
14d ago
|
8-K
| $55.97 $55.41 | ▼ −1.00% | ▼ −1.15% | $54.63 (−2.39%) |
|
May 27, 2026
16d ago
|
Press Release
| $54.05 $55.16 | ▲ +2.05% | ▲ +1.81% | $54.63 (+1.07%) |
|
May 12, 2026
4w ago
|
Press Release
| $52.66 $51.96 | ▼ −1.33% | ▼ −1.91% | $54.63 (+3.74%) |
|
May 8, 2026
5w ago
|
Press Release
| $53.53 $52.16 | ▼ −2.56% | ▼ −2.79% | $54.63 (+2.05%) |
|
Apr 14, 2026
8w ago
|
Insider Cluster
| $51.16 $50.76 | ▼ −0.78% | ▼ −1.56% | $54.63 (+6.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access